Results 211 to 220 of about 92,879 (318)

Antimicrobial resistance in the Nordics: mapping existing surveillance systems and assessing the impact of COVID-19 using regression models. [PDF]

Antimicrob Resist Infect Control
Tran TT, Krolicka A, Tiwari A, Pitkänen T, Lood R, Ásmundsdóttir ÁM, Wikmark OG.   +6 more
europepmc   +1 more source

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

European Respiratory Journal, 2012
D. Falzon, N. Gandhi, G. Migliori, G. Sotgiu, H. Cox, T. Holtz, M. Hollm-Delgado, S. Keshavjee, K. Deriemer, R. Centis, L. D’Ambrosio, C. Lange, M. Bauer, D. Menzies   +13 more
semanticscholar   +1 more source

Fluoroquinolone Treatment Failure in Gonorrhea

, 1997
Takashi Deguchi, Isao Saito, Mayumi Tanaka, Kenichi Sato, K Deguchi, Mitsuru Yasuda, Masahiro Nakano, Yoshinori Nishino, Emiko Kanematsu, S Ozeki, Yukimichi Kawada   +10 more
openalex   +1 more source

Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli [PDF]

, 1996
Peter Heisig
openalex   +1 more source

Quinoline ATP Synthase Inhibitors with Activity Against Multidrug Resistant Acinetobacter baumannii and Pseudomonas aeruginosa

ChemMedChem, Volume 20, Issue 10, May 19, 2025.
Targeting ATP synthase in Gram‐negative pathogens. Presented is the first disclosure of quinoline‐derived antibiotics inhibiting multidrug resistant Acinetobacter baumannii ATP synthase and expansion of the structure activity relationship profile of Pseudomonas aeruginosa ATP synthase inhibitors.
Katie T. Ward, Alexander P. L. Williams, Angelina L. Dennison, Lena Aamir, Darien L. Allen, Britza Chavez‐Arellano, Toni A. Marchlewski, Mars L. Zappia, Amanda L. Wolfe, P. Ryan Steed   +9 more
wiley   +1 more source

Population-Level Frequency of Fluoroquinolone Resistance by Whole-Genome Sequencing Drug Predictions in Mycobacterium tuberculosis Complex Isolates in England From 2017 Through 2023. [PDF]

Clin Infect Dis
Ferran E, Chan C, Sheikh N, Dedicoat M, Alexander E, Gibertoni-Cruz A, Brown J, Robinson E, Lipman M.   +8 more
europepmc   +1 more source

Impact of Pharmacovigilance Interventions Targeting Fluoroquinolones on Antibiotic Use in the Netherlands and the United Kingdom. [PDF]

Pharmacoepidemiol Drug Saf
Lasys T, Santa-Ana-Tellez Y, Siiskonen SJ, Groenwold RHH, Gardarsdottir H.   +4 more
europepmc   +1 more source

Lactic Acid Polymers as Biodegradable Carriers of Fluoroquinolones: An In Vitro Study [PDF]

, 1999
Kyriaki Kanellakopoulou, Maria Kolia, Antonios Anastassiadis, Themistoklis Korakis, Evangelos J. Giamarellos‐Bourboulis, A. G. Andreopoulos, Eleftherios Dounis, Helen Giamarellou   +7 more
openalex   +1 more source

In-vitro antimicrobial activity of new antimicrobial agents against Streptococcus pneumoniae and potential resistance mechanisms: a multicenter study. [PDF]

BMC Microbiol
Lei Z, Liu Q, Ma Y, Yang X, Zu H, Li Z, Zhang F, Pu D, Zhang Y, Lu B.   +9 more
europepmc   +1 more source

Sorption of fluoroquinolones and sulfonamides in 13 Brazilian soils.

Chemosphere, 2013
Rafael Marques Pereira Leal, L. Alleoni, V. L. Tornisielo, J. B. Regitano   +3 more
semanticscholar   +1 more source